• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    RXi Pharmaceuticals Corporation (RXII)

    -NasdaqCM
    1.16 Down 0.03(2.52%) Feb 27, 3:58PM EST
    |Pre-Market : 1.10 Down 0.06 (5.17%) 8:18AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:1.19
    Open:1.19
    Bid:1.10 x 2700
    Ask:1.20 x 3000
    1y Target Est:9.00
    Beta:2.66
    Next Earnings Date:N/A
    Day's Range:1.16 - 1.21
    52wk Range:0.91 - 6.50
    Volume:65,660
    Avg Vol (3m):211,569
    Market Cap:24.51M
    P/E (ttm):N/A
    EPS (ttm):-0.99
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for RXII

    Comparison

    Symbol% ChgMkt Cap
    RXIIDown 2.52%24.51M
    AGNUp 0.15%69.88B
    ALNYDown 2.74%8.50B
    MRNAUp 1.54%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):292.41
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.80
    Quarterly EPS Est (Dec-14) :-0.14
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    RXi Pharmaceuticals Corporation, a biotechnology company, focuses on discovering, developing, and commercializing therapies based on its proprietary, next-generation RNA interference (RNAi) platform. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback